Navigation Links
Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer

nk" title= "Click to search for citations by this author." href= "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Planas+J%22%5BAuthor%5D"> Planas J, Camell H. Breakthrough cancer pain: prevalence and characteristics in patients in Catalonia, Spain. Journal of Pain and Symptom Management 2002;24:45–52

3. Zeppetella G O’Doherty CA, Collins S. Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice. Journal of Pain and Symptom Management 2000;20:87–92

4. Portenoy R and Hagen NA. Breakthrough pain; definition, prevalence, and characteristics. Pain 1990;41:273–281

5. Davies A. The art of breakthrough pain treatment. Presented in Challenges in treating breakthrough pain satellite symposium at the 10th Congress of the European Association for Palliative Care, Budapest, Hungary, 7 June 2007






Page: 1 2 3 4 5 6

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
3. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
4. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
5. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
6. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
7. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
8. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
9. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial

Post Your Comments:
(Date:11/9/2009)... Access MediQuip, LLC, the nation,s first and larg...ice management solutions to the healthcare industr...rate headquarters to Lake Mary, Florida. The move...ncludes a major expansion of the Primera Blvd, Lak... and relocation and expansion of the Houston facil...
(Date:11/9/2009)... ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), toda...Bepreve(TM) (bepotastine besilate ophthalmic solut... were presented in poster sessions at the 2009 Ann...thma & Immunology (ACAAI) in Miami Beach, FL. ... of Ocular Itching with Bepotastine Besilate Ophth...
(Date:11/9/2009)...- Thomson Reuters today announced the newest rel...inical surveillance solution that enables hospital...spond immediately to improve clinical quality and ... is available to current CareFocus customers at no...everal powerful enhancements that improve clinical...
Breaking Medicine Technology:Access MediQuip Moves Company Headquarters to Lake Mary, Florida 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3Regence to Cover Administration Costs of H1N1 Vaccine for Fully Insured Groups Individuals This Flu Season 5044 1Regence to Cover Administration Costs of H1N1 Vaccine for Fully Insured Groups Individuals This Flu Season 5044 2Regence to Cover Administration Costs of H1N1 Vaccine for Fully Insured Groups Individuals This Flu Season 5044 3New research reveals the ancestral populations of India and their relationships to modern groups 14244 1New research reveals the ancestral populations of India and their relationships to modern groups 14244 2New research reveals the ancestral populations of India and their relationships to modern groups 14244 3Caraco Pharmaceutical Laboratories Ltd Announces Resignation of Georges Ugeux from Board of Directors 58209 1Caraco Pharmaceutical Laboratories Ltd Announces Resignation of Georges Ugeux from Board of Directors 58209 2Caraco Pharmaceutical Laboratories Ltd Announces Resignation of Georges Ugeux from Board of Directors 58209 3
(Date:11/9/2009)... , WASHINGTON, Nov. 9 /PRNewswire-USNewswire/...tatement praising provisions in the Affordable Hea... improve access to Medicaid and reduce Medicare Pa...962 passed the House on Saturday by a vote of 220 ...roved both health and quality of life for thousand...
(Date:11/9/2009)... , PITTSFIELD, Maine, Nov. 9 ...pients in Maine are increasingly concerned about f...a competitive Medicare option for 2010. ,, The ...ion (PPO) Medicare Advantage plan provides a cost-...l Medicare or a Medicare Supplement plan. People ...
(Date:11/9/2009)... , WASHINGTON, Nov. 9 /PRNewswire-USNewswire/...AAPA), representing more than 75,000 clinically pr...the United States, applauds the U.S. House of Repr...eform bill, H.R. 3962, the Affordable Health Care ...d that this reform bill will ultimately lower the ...
(Date:11/9/2009)... , St. Jude Children,s Research Hospital and the ...e formed a collaboration to provide proton therapy...he approval of the first clinical study to evaluat... in children younger than 3 years old. , Under...ts to receive proton therapy at the UF Proton Ther...
(Date:11/9/2009)... , PHILADELPHIA November 9, 2009 Shire plc (LSE...rmaceutical company, today announced the availabil...ts in pharmacies across the United States for the ...der (ADHD) in children and adolescents ages 6 to 1...e, is the first and only nonscheduled alpha-2A rec...
Breaking Medicine News(10 mins):Health News:Pelosi Applauds Provisions in Health Bill to Improve Access to Care, Medications for People Living With HIV/AIDS 2Health News:Maine Residents With Medicare Searching for Affordable and Innovative Insurance Have Competitive Medicare Advantage Option 2Health News:American Academy of Physician Assistants Applauds U.S. House of Representatives for Passing Health Care Reform Bill 2Health News:St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 3Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 4
... Brown & Toland Medical Group,today announced a s...ting,income of $12 million on total revenues of $2...iving approximately $4 million for,pay for perform...s to eligible physicians. In 2007 Brown & Toland,p...
...epressant cut inflammation in relapsing remitting...y News) -- Prozac may help reduce disease activity...ltiple sclerosis (MS), a new study suggests. , For...scans were conducted every four weeks to monitor t...
...seem to cause drop in heart rate variability, rese...ealthDay News) -- Results of a small study show th...s affect the heart rates of newborn babies, Italia...fants who can spend several weeks or months in inc...
...s on outlook for combined entity during its Q1 200..., LISLE, IL, April 30 /PRNewswire-FirstCall/ - SX...(NASDAQ: SXCI , TSX: SXC), a leading provider,of ... acquisition of NMHC by SXC has been completed. SX...
...nly Treatment Approved to Both Reduce Exacerbation... RESEARCH TRIANGLE PARK, N.C., April 30 The,U.S....r Diskus(R) 250/50,(fluticasone propionate 250 mcg...history of exacerbations. With this,approval, Adva...
... Counter to CDC Recommendations, CINCINNATI, Apri... has found that U.S. mothers report they are less ... human papillomavirus virus (HPV),even though the ... for younger daughters, say researchers at Cincinn...
Other Medicine News:Health News:Brown & Toland Announces 2007 Financial Results 2Health News:Prozac Reduces Disease Activity in MS Patients 2Health News:Incubators Affect Newborns' Heart Rates 2Health News:SXC Health Solutions completes acquisition of NMHC 2Health News:FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD 2Health News:FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD 3Health News:FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD 4Health News:Mothers Less Likely to Pursue HPV Vaccination for Youngest Daughters 2Health News:Mothers Less Likely to Pursue HPV Vaccination for Youngest Daughters 3Health News:Mothers Less Likely to Pursue HPV Vaccination for Youngest Daughters 4
ENDO STITCHtrade; Single-Stitch SOFSILKtrade;
...ient-use instrument designed to assist endoscopica...re and a secure knot intracorporeally -- just push...It is designed for use with the ENDOPATH 5mm troca...ent has two levers: the control lever facilitates ...
ENDOKNOT Suture Type - 0 Coated VICRYL
ENDOLOOP Suture Type - 0 PDSII
Medicine Products: